NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
InnoCan Pharma Corporation (OTCQB: INNPF)
INNPF Technical Analysis
5
As on 15th Oct 2025 INNPF STOCK Price closed @ 12.34 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.22 & Strong Buy for SHORT-TERM with Stoploss of 0.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INNPFSTOCK Price
Open | 12.34 | Change | Price | % |
High | 12.34 | 1 Day | 12.18 | 7612.50 |
Low | 12.34 | 1 Week | 12.23 | 11118.18 |
Close | 12.34 | 1 Month | 12.25 | 13611.11 |
Volume | 20 | 1 Year | 12.20 | 8714.29 |
52 Week High 0.34 | 52 Week Low 0.09 |
OTCQB USA Most Active Stocks
WDLF | 0.00 | % |
EMED | 0.00 | % |
SCWO | 0.48 | -7.69% |
GCAN | 0.00 | % |
BMIX | 0.01 | % |
FMCC | 4.94 | 12.53% |
ALPP | 3.56 | -100.00% |
ALPP | 3.56 | -100.00% |
SILO | 0.66 | 6.45% |
CBDS | 0.06 | -25.00% |
OTCQB USA Top Gainers Stocks
OTCQB USA Top Losers Stocks
INNPF Daily Charts |
INNPF Intraday Charts |
Whats New @ Bazaartrend |
INNPF Free Analysis |
|
INNPF Important Levels Intraday
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
RESISTANCE | 12.34 |
INNPF Forecast October 2025
4th UP Forecast | 12.4 |
3rd UP Forecast | 12.38 |
2nd UP Forecast | 12.37 |
1st UP Forecast | 12.36 |
1st DOWN Forecast | 12.32 |
2nd DOWN Forecast | 12.31 |
3rd DOWN Forecast | 12.3 |
4th DOWN Forecast | 12.28 |
INNPF Weekly Forecast
4th UP Forecast | 12.44 |
3rd UP Forecast | 12.41 |
2nd UP Forecast | 12.39 |
1st UP Forecast | 12.37 |
1st DOWN Forecast | 12.31 |
2nd DOWN Forecast | 12.29 |
3rd DOWN Forecast | 12.27 |
4th DOWN Forecast | 12.24 |
INNPF Forecast2025
4th UP Forecast | 35.95 |
3rd UP Forecast | 28.38 |
2nd UP Forecast | 23.7 |
1st UP Forecast | 19.02 |
1st DOWN Forecast | 5.66 |
2nd DOWN Forecast | 0.98 |
3rd DOWN Forecast | -3.7 |
4th DOWN Forecast | -11.27 |
InnoCan Pharma Corporation ( OTCQB USA Symbol : INNPF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INNPF Other Details
Segment | EQ | |
Market Capital | 150342064.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-Specialty & Generic | |
Offical website | > echo $website ; ?> |
INNPF Address
![]() |
INNPF Latest News
INNPF Business Profile
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel. It engages in the research and development of Covid-19 treatment by using CBD loaded exosomes; and CBD loaded liposomes. The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products. In addition, it develops SHIR premium CBD facial serum products. The company was incorporated in 2018 and is based in Calgary, Canada. Address: 1015, 926 - 5 Avenue SW, Calgary, AB, Canada, T2P 0N7
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service